Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
Latest Information Update: 15 Jan 2021
At a glance
- Drugs GSK 2321138A (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 08 Feb 2019 New trial record